3 Things Could Make Or Break An ANDA

Law360 (May 1, 2008, 12:00 AM EDT) -- Here are the top three factors that generics drugmakers should take into account when preparing to submit an abbreviated new drug application with the U.S. Food and Drug Administration.

How carefully companies consider these factors and which decisions they make at this stage can ultimately affect their approach to litigation — and how successful the lawsuit is, experts say.

One: Am I going to be sued?

Prior to making any other move in preparing to fight for the right to market a generic medication, a generic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.